Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|November 18, 2023
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USADavid W Dodick, Peter J Goadsby, Todd J Schwedt, et al.
Journal of Pain Research|January 10, 2024
A Randomized Controlled Trial of Clinical Hypnosis as an Opioid-Sparing Adjunct Treatment for Pain Relief in Adults Undergoing Major Oncologic SurgeryBrittany N Rosenbloom, P Maxwell Slepian, Muhammed Abid Azam, et al.
Neurology|August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe PainRichard B Lipton, David W Dodick, Peter J Goadsby, et al.
Headache|July 3, 2026
Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension studyDale S Bond, Jonathan H Smith, Alexandra Sinclair, et al.
The Journal of Physical Chemistry. A|August 7, 2008
Ultrafast spectroscopy of the uranium(IV) and thorium(IV) bis(ketimide) complexes (C5Me5)2An[-N=C(Ph)(CH2Ph)]2 (An = Th, U)David J Hilton, Rohit P Prasankumar, Eric J Schelter, et al.
Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.
Neurology. Clinical Practice|October 14, 2024
Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening PeriodTodd J Schwedt, Richard B Lipton, Peter J Goadsby, et al.
American Journal of Human Genetics|January 1, 1991
Identification of a highly polymorphic microsatellite VNTR within the argininosuccinate synthetase locus: exclusion of the dystonia gene on 9q32-34 as the cause of dopa-responsive dystonia in a large kindredD J Kwiatkowski, T G Nygaard, D E Schuback, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2017
Smoking, Pain Intensity, and Opioid Consumption 1-3 Months After Major Surgery: A Retrospective Study in a Hospital-Based Transitional Pain ServiceJanice J Montbriand, Aliza Z Weinrib, Muhammad A Azam, et al.
Cephalalgia : an International Journal of Headache|September 15, 2021
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trialTodd J Schwedt, Richard B Lipton, Jessica Ailani, et al.
Pageof 25